Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Abstract

This is the first randomized clinical trial demonstrating the benefit of a disease-modifying therapy in preventing a first acute clinical event in people with RIS. ANN NEUROL 2023;93:604-614.